logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

SAINT BELLA GP (02508) repurchased 78,500 shares for HK$212,800 on October 15.

date
20:10 15/10/2026
avatar
GMT Eight
SAINT BELLA GP (02508) announced that on October 15, 2026, it repurchased 78,500 shares for HK$212,800.
SAINT BELLA GP (02508) announced that on October 15, 2026, it repurchased 78,500 shares for HK$212,800.
Related Articles
AI + Automotive Dual Engines Driving Growth! StoneX Initiates onsemi (ON.US) with a "Buy" Rating, Stock Price Could Rise Another 50%
HK Stock
KAFELAKU COFFEE (01869): Zhu Haoqin has been appointed as an independent non-executive director.
China Stock
Beijing Hotgen Biotech Co.,Ltd(688068.SH) subsidiary SGC001 innovative drug "expected severe acute pancreatitis" indication Phase II clinical study completed first subject enrollment and dosing
AI + Automotive Dual Engines Driving Growth! StoneX Initiates onsemi (ON.US) with a "Buy" Rating, Stock Price Could Rise Another 50%
KAFELAKU COFFEE (01869): Zhu Haoqin has been appointed as an independent non-executive director.
HK Stock
Beijing Hotgen Biotech Co.,Ltd(688068.SH) subsidiary SGC001 innovative drug "expected severe acute pancreatitis" indication Phase II clinical study completed first subject enrollment and dosing
China Stock
RECOMMEND
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
icon
25/09/2026
From IT Services to Enterprise AI: What ATGL Must Prove Next
From IT Services to Enterprise AI: What ATGL Must Prove Next
icon
24/09/2026
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.